Randomized clinical trial: Combination antiretroviral therapy with tenofovir-emtricitabine and lopinavir-ritonavir in patients with primary biliary cholangitis

BACKGROUND: Prior studies using reverse transcriptase inhibitors to treat a human betaretrovirus (HBRV) in patients with primary biliary cholangitis (PBC) resulted in a 21% reduction in alkaline phosphatase (ALP). Herein, we studied the safety and efficacy of combination tenofovir-emtricitabine (TDF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can Liver J
Main Authors: Lytvyak, Ellina, Hosamani, Ishwar, Montano-Loza, Aldo J, Saxinger, Lynora, Mason, Andrew L
Formato: Artigo
Idioma:Inglês
Publicado em: University of Toronto Press 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8112609/
https://ncbi.nlm.nih.gov/pubmed/33981960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3138/canlivj.2018-0020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados